Literature DB >> 21148410

Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells.

Florentina Pluteanu1, Leanne L Cribbs.   

Abstract

Arterial smooth muscle cells enter the cell cycle and proliferate in conditions of disease and injury, leading to adverse vessel remodeling. In the pulmonary vasculature, diverse stimuli cause proliferation of pulmonary artery smooth muscle cells (PASMCs), pulmonary artery remodeling, and the clinical condition of pulmonary hypertension associated with significant health consequences. PASMC proliferation requires extracellular Ca(2+) influx that is intimately linked with intracellular Ca(2+) homeostasis. Among the primary sources of Ca(2+) influx in PASMCs is the low-voltage-activated family of T-type Ca(2+) channels; however, up to now, mechanisms for the action of T-type channels in vascular smooth muscle cell proliferation have not been addressed. The Ca(v)3.1 T-type Ca(2+) channel mRNA is upregulated in cultured PASMCs stimulated to proliferate with insulin-like growth factor-I (IGF-I), and this upregulation depends on phosphatidylinositol 3-kinase/Akt signaling. Multiple stimuli that trigger an acute rise in intracellular Ca(2+) in PASMCs, including IGF-I, also require the expression of Ca(v)3.1 Ca(2+) channels for their action. IGF-I also led to cell cycle initiation and proliferation of PASMCs, and, when expression of the Ca(v)3.1 Ca(2+) channel was knocked down by RNA interference, so were the expression and activation of cyclin D, which are necessary steps for cell cycle progression. These results confirm the importance of T-type Ca(2+) channels in proper progression of the cell cycle in PASMCs stimulated to proliferate by IGF-I and suggest that Ca(2+) entry through Ca(v)3.1 T-type channels in particular interacts with Ca(2+)-dependent steps of the mitogenic signaling cascade as a central component of vascular remodeling in disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148410      PMCID: PMC3063981          DOI: 10.1152/ajpcell.00107.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  37 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

Review 2.  Molecular characterization of T-type calcium channels.

Authors:  E Perez-Reyes
Journal:  Cell Calcium       Date:  2006-06-08       Impact factor: 6.817

Review 3.  T-type Ca2+ channels in vascular smooth muscle: multiple functions.

Authors:  Leanne L Cribbs
Journal:  Cell Calcium       Date:  2006-06-23       Impact factor: 6.817

Review 4.  T-type calcium channels in differentiation and proliferation.

Authors:  Philippe Lory; Isabelle Bidaud; Jean Chemin
Journal:  Cell Calcium       Date:  2006-06-21       Impact factor: 6.817

5.  Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.

Authors:  David M Rodman; Katherine Reese; Julie Harral; Brian Fouty; Songwei Wu; James West; Marloes Hoedt-Miller; Yuji Tada; Kai-Xun Li; Carlyne Cool; Karen Fagan; Leanne Cribbs
Journal:  Circ Res       Date:  2005-03-17       Impact factor: 17.367

6.  Remodeling excitation-contraction coupling of hypertrophied ventricular myocytes is dependent on T-type calcium channels expression.

Authors:  Satoshi Takebayashi; Yulong Li; Toshihiko Kaku; Shuichiro Inagaki; Yutaka Hashimoto; Kazuhiro Kimura; Shinji Miyamoto; Tetsuo Hadama; Katsushige Ono
Journal:  Biochem Biophys Res Commun       Date:  2006-05-05       Impact factor: 3.575

7.  Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.

Authors:  Y Imai; D R Clemmons
Journal:  Endocrinology       Date:  1999-09       Impact factor: 4.736

8.  T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.

Authors:  Mitsuru Horiba; Takao Muto; Norihiro Ueda; Tobias Opthof; Keiko Miwa; Mayumi Hojo; Jong-Kook Lee; Kaichiro Kamiya; Itsuo Kodama; Kenji Yasui
Journal:  Life Sci       Date:  2007-12-04       Impact factor: 5.037

9.  The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.

Authors:  Chien-Sung Chiang; Ching-Hui Huang; Hockling Chieng; Ya-Ting Chang; Dory Chang; Ji-Jr Chen; Yong-Cyuan Chen; Yen-Hui Chen; Hee-Sup Shin; Kevin P Campbell; Chien-Chang Chen
Journal:  Circ Res       Date:  2009-01-02       Impact factor: 17.367

10.  Molecular and electrical remodeling of L- and T-type Ca(2+) channels in rat right atrium with monocrotaline-induced pulmonary hypertension.

Authors:  Takashi Koyama; Kyoichi Ono; Hiroyuki Watanabe; Takayoshi Ohba; Manabu Murakami; Kenji Iino; Hiroshi Ito
Journal:  Circ J       Date:  2008-12-26       Impact factor: 2.993

View more
  12 in total

1.  Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.

Authors:  Rasha R Abd El-Rahman; Osama F Harraz; Suzanne E Brett; Yana Anfinogenova; Rania E Mufti; Daniel Goldman; Donald G Welsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-26       Impact factor: 4.733

2.  Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.

Authors:  Haiyang Tang; Jiwang Chen; Dustin R Fraidenburg; Shanshan Song; Justin R Sysol; Abigail R Drennan; Stefan Offermanns; Richard D Ye; Marcelo G Bonini; Richard D Minshall; Joe G N Garcia; Roberto F Machado; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

3.  Stimulated phosphorylation of ERK in mouse kidney mesangial cells is dependent upon expression of Cav3.1.

Authors:  Sudha Priya Soundara Pandi; Michael J Shattock; Bruce M Hendry; Claire C Sharpe
Journal:  BMC Nephrol       Date:  2022-06-16       Impact factor: 2.585

4.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Regulation of ca(2+) signaling in pulmonary hypertension.

Authors:  Amy L Firth; Jun Yeon Won; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

6.  Depolarization-dependent contraction increase after birth and preservation following long-term hypoxia in sheep pulmonary arteries.

Authors:  Demosthenes G Papamatheakis; Jay J Patel; Quintin Blood; Travis T Merritt; Lawrence D Longo; Sean M Wilson
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

7.  1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.

Authors:  Mauro Cataldi; Fiorentina Bruno
Journal:  Transl Med UniSa       Date:  2012-10-11

8.  Benidipine protects kidney through inhibiting ROCK1 activity and reducing the epithelium-mesenchymal transdifferentiation in type 1 diabetic rats.

Authors:  Ganlin Wu; Meirong Xu; Kui Xu; Yilan Hu
Journal:  J Diabetes Res       Date:  2013-12-01       Impact factor: 4.011

9.  Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels.

Authors:  Hayley Duckles; Hannah E Boycott; Moza M Al-Owais; Jacobo Elies; Emily Johnson; Mark L Dallas; Karen E Porter; Francesca Giuntini; John P Boyle; Jason L Scragg; Chris Peers
Journal:  Pflugers Arch       Date:  2014-04-18       Impact factor: 3.657

10.  Contribution of S4 segments and S4-S5 linkers to the low-voltage activation properties of T-type CaV3.3 channels.

Authors:  Ana Laura Sanchez-Sandoval; Zazil Herrera Carrillo; Clara Estela Díaz Velásquez; Dulce María Delgadillo; Heriberto Manuel Rivera; Juan Carlos Gomora
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.